Accordingly, the present review on human IGF2 gene regulation focuses, specifically, on integrating the current understanding of IGF2 gene epigenetic control with the underlying mechanisms occurring at its promoter and transcript (mRNA) levels in cancer and IGF2-expression syndromes. The gene discussed is IGF2; the disease is cancer.